FERTIN PHARMA A/S: Financial statements 2014
CVR: 25834844
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 694,057,000 and a net result of DKK 42,229,000. The profit margin was 6.1%. Equity in the 2014 report amounted to DKK 494,988,000. The solvency ratio was 47.4%. The company had 446 employees in the financial year.
- Revenue
- DKK 694,057,000
- Gross Profit
- DKK 419,487,000
- Profit/Loss
- DKK 42,229,000
- Equity
- DKK 494,988,000
- Total Assets
- DKK 1,043,812,000
- Employees
- 446
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
FERTIN PHARMA A/S has published its annual report for 2013.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.